Maj has a quick discussion with $CCEL CEO David Portnoy about current events going on at the company. CCEL provides private and public cord blood banking solutions for stem cell treatments. Specifically, David addressed questions on Revenue trends, Birth rate cause and effect on the company, Pricing environment, Expenditures and run rates, The company’s clinic plans, The shift in revenue expectations, FDA approval goals, Therapy pipeline
We learn more about Cryo-cell International, Inc (OTC:CCEL) via a conversation with the company’s Co-CEO, David Portnoy. We view this as a preparatory call to be able to have a fuller live Zoom Fireside Chat with members present. Please enjoy!